top of page

iPROLEPSIS presented at DSAI 2026

26/06/2026

Digital biomarkers, serious games and AI-supported health monitoring

iPROLEPSIS was represented at DSAI 2026, the 12th International Conference on Software Development and Technologies for Enhancing Accessibility and Fighting Info-exclusion, held from 23 to 25 June 2026 in Alexandroupolis, Greece.


The project contributed to several sessions and presentations focused on digital biomarkers, multimodal digital phenotyping, serious games, artificial intelligence and health monitoring.


Prof. Leontios Hadjileontiadis from Aristotle University of Thessaloniki (AUTH), coordinator of iPROLEPSIS, moderated the Opening Panel titled “Translational Research in Rehabilitation, Digital Inclusiveness and Education in the Era of AI”. He also presented the paper “Multimodal Digital Phenotyping in Psoriatic Arthritis, Parkinson’s Disease, and Breast Cancer: Tri-project Insights from iPROLEPSIS, AI-PROGNOSIS, and REBECCA”.


In addition, Prof. Hadjileontiadis, Vasilis Charisis and Stelios Hadjidimitriou from AUTH co-chaired the Special Track “Digital Biomarkers’ Potentialities: From Digital Phenotyping to Systemic Thinking in Health and Education”.


Vasilis Charisis from AUTH also chaired the session “Artificial Intelligence and Emerging Technologies in Education”.


The iPROLEPSIS Serious Games were presented by Bárbara Ramalho from FMH ULisboa, who gave a presentation titled “Digital Biomarkers in Serious Games for Patients with Psoriatic Arthritis: The iPROLEPSIS Games Paradigm”. Her presentation showcased how the iPROLEPSIS mobile game suite, co-designed with patients and clinicians, captures multimodal digital biomarkers through Breathing games, Exergames and NoPain games using smartphone and smartwatch sensors. These signals include heart rate, stress, breathing accuracy, mobility and motor control, supporting continuous, real-world monitoring and contributing to digital phenotyping in Psoriatic Arthritis.


The project’s participation in DSAI 2026 highlighted the role of iPROLEPSIS in advancing digital biomarker-based approaches for Psoriatic Arthritis monitoring, serious games and AI-supported health innovation.


bottom of page